OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

News

Keep up to date with the latest news items from GAFFI.

GAFFI calls together experts in Lima to formulate new thinking on fungal disease management in Latin America

Posted .

September 3-5th over 60 fungal disease experts from Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay and Venezuela convened in Lima, Peru  to discuss integration of new diagnostic tools that focus on antigen and antibody detection PCR (commercial and standardized) and MALDI-TOF identification… Read more »

Read more >

Hyper-endemic areas for histoplasmosis revealed in new SE Asian maps

Posted .

Researchers from Manchester (UK) and Jakarta (Indonesia) have published new prevalence data for histoplasmosis exposure for multiple countries in SE Asia. Sensitivity to the histoplasmin skin test was seen in a large proportion of the population (26-86%), so it is likely that rolling out the Histoplasma antigen test (now on the WHO Essential Diagnostics List) will help to diagnose cases and save lives.

Read more >

Dr Swarup Sarkar joins GAFFI as a Senior Advisor

Posted .

Swarup Sarkar is an Indian physician, epidemiologist, public health professional and diplomat known for his works in the field of Infectious Diseases and HIV/AIDS in particular. Sarkar served as the Director of Communicable Diseases of the World Health Organization, South East Asia Regional Office (WHO SEARO) and is currently an advisor to international health agencies…. Read more »

Read more >

ECCMID 2019 presentations: burden of fungal disease estimates for Namibia, Paraguay and Kyrgyzstan; and fungal keratitis leads to over 600,000 blind eyes annually

Posted .

Over 1.1 million cases of fungal keratitis are documented annually, leading to >100,000 perforated or surgically removed eyes and >500,000 blind eyes, according to a team from the University of Manchester, London School of Hygiene and Tropical Medicine and GAFFI. Lottie Brown presented this systematic review at Europe’s premier infection meeting ECCMID (Amsterdam) earlier this… Read more »

Read more >

1 in 15 TB sufferers go on to develop chronic pulmonary aspergillosis, treatment could save 1000s of lives

Posted .

Around 1 in 15 people affected by tuberculosis are likely get the treatable fungal infection aspergillosis, according to research published today in the European Respiratory Journal by experts at the University of Manchester (UK) and Gulu Regional Referral Hospital (Uganda). The new knowledge could influence TB programs by helping doctors to identify – and treat… Read more »

Read more >